The “Translational Unraveling of Precision Acute Care (TUPAC)” research team at CHU de Clermont-Ferrand (Pr. Matthieu Jabaudon & Pr. Marc Garnier) is recruiting a post-doctoral researcher to lead a 3-year project on acute respiratory distress syndrome (ARDS): development of a macrophage-reprogramming therapy using targeted nanoparticles in preclinical models (in vitro/ex vivo/in vivo), prospective multicenter clinical cohort for multimodal and longitudinal phenotyping.
✅ PhD in cell/molecular biology, life sciences, medicine or a related field
✅ Experience in animal experimentation (FELASA Level B) and/or translational clinical research is a plus
📍 Clermont-Ferrand University Hospital — within the iGReD (Institut de Génétique, Reproduction et Développement) translational ecosystem and the upcoming Clinical Investigation Center (#CIC) 2027–2032 project
INSERM Inserm Auvergne-Rhône-Alpes Direction générale de l’offre de soins (DGOS) Université Clermont Auvergne Institut SVSAE UCA (Sciences de la Vie, Santé, Agronomie, Environnement) UFR de Médecine et des Professions Paramédicales
📅 3-year contract — preferred start (flexible): October 2026
Driven and eager to join a growing research team? Get in touch!
More details 👉 here
Tagged as: Life Sciences
Postdoctoral Position in Machine Learning for Peptide Membrane Permeability PredictionLocation: GEC Laboratory, CNRS/Picardie University, Amiens, FranceDuration: 12 months (start date...
ApplyPostdoctoral Researcher Position Position Location: Saint-Priest (Lyon), France Type of contract: Post PhD Contract We are seeking a highly motivated...
ApplyPlease send your application to mjabaudon@chu-clermontferrand.fr
Don't forget to mention that you found the position on jobRxiv!
